proprietary戊酸二氟可龙外用制剂的比较变白活性

Comparative blanching activities of proprietary diflucortolone valerate topical preparations.

作者信息

Coleman G L, Kanfer I, Haigh J M

出版信息

Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920.

DOI:10.1159/000250920

Abstract

The blanching activities and hence bioavailabilities of the cream, ointment and fatty ointment preparations of Nerisone and Temetex (diflucortolone valerate 0.1%) were evaluated using an occluded and unoccluded blanching assay. These products were compared to Synalar ointment and cream (fluocinolone acetonide 0.025%), established topical corticosteroid preparations. Statistical analysis showed no significant differences between similar formulations of diflucortolone valerate. Significant differences were noted between diflucortolone valerate and fluocinolone acetonide preparations.

摘要

采用封包和非封包变白试验，对Nerisone和Temetex（戊酸二氟可龙0.1%）乳膏、软膏和脂肪性软膏制剂的变白活性及生物利用度进行了评估。将这些产品与已有的外用皮质类固醇制剂Synalar软膏和乳膏（醋酸氟轻松0.025%）进行比较。统计分析表明，戊酸二氟可龙类似制剂之间无显著差异。戊酸二氟可龙制剂和醋酸氟轻松制剂之间存在显著差异。

相似文献

1

Comparative blanching activities of proprietary diflucortolone valerate topical preparations. proprietary戊酸二氟可龙外用制剂的比较变白活性

Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920.

2

Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.

Dermatologica. 1976;153(4):236-42. doi: 10.1159/000251062.

3

Comparative blanching activities of locally manufactured proprietary fluocinolone acetonide topical preparations.本地生产的专利氟轻松丙酮 topical 制剂的比较脱色活性。（注：这里“topical”结合语境可能更准确的意思是“局部用的”，整句可优化为“本地生产的专利氟轻松丙酮局部用制剂的比较脱色活性” ）

S Afr Med J. 1979 Sep 8;56(11):447-9.

4

[Topical treatment of dermatoses with difluocortolone valerate fatty ointment].

Z Hautkr. 1976;51 Suppl 1:27-9.

5

[Double-blind comparative study between difluocortolone-valerianate and fluocinolone-acetonide ointments].戊酸二氟可的索与醋酸氟轻松软膏的双盲对照研究

Prensa Med Mex. 1977 Mar-Apr;42(3-4):183-6.

6

[Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].新型皮质类固醇戊酸二氟可龙乳膏、软膏和脂肪性软膏的多中心临床试验。第一部分：戊酸二氟可龙与氟可龙、己酸酯、新戊酸酯在双侧双盲局部应用设计中的对比研究（作者译）

Arzneimittelforschung. 1976;26(7b):1499-504.

7

[Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].

Z Hautkr. 1976;51 Suppl 1:1-16.

8

A multicentric clinical trial with 0.1% diflucortolone valerate in Thailand.在泰国进行的一项使用0.1%戊酸地氟米松的多中心临床试验。

J Med Assoc Thai. 1977 Aug;60(8):353-61.

9

[Efficacy of diflucortolone valerate in the vasoconstriction tests].戊酸二氟可龙在血管收缩试验中的疗效

Arzneimittelforschung. 1976;26(7b):1495-8.

10

[Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].新型皮质类固醇戊酸二氟可龙乳膏、软膏和脂肪性软膏的多中心临床试验。第二部分：与几种市售制剂的对比研究（作者译）

Arzneimittelforschung. 1976;26(7b):1504-9.

引用本文的文献

1

Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations.采用卵磷脂/壳聚糖纳米粒增强二氟可龙戊酸酯的透皮传递：体外与体内评价。

Int J Nanomedicine. 2013;8:461-75. doi: 10.2147/IJN.S40519. Epub 2013 Jan 30.

2

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.对美国食品药品监督管理局（FDA）提议的用于局部用皮质类固醇生物等效性测试的剂量反应试验方法的评估。

Pharm Res. 1998 Jan;15(1):4-7. doi: 10.1023/a:1011980115866.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。